like us on facebook connect with us on linkedin follow us on twitter March 15, 2023

To learn more about BMS's Opdualag as a Regimen for Metastatic or Unresectable Cutaneous Melanoma, CLICK HERE.

Section Header Section Header Section Header

MSHO Featured Corporate Sponsor Assistance Programs

• Astellas Pharma Support Solution
• Exelixis Access Services® (EASE)
• PharmaEssentia SOURCE

Details >
Section Header

WPS Oncology Related LCD Updates

No updates relating to oncology / hematology for March

Details >

WPS Recent Oncology Related News

• Customer Service Training
• Fee Schedules
• Medicare Hot Links

Details >
Section Header

CMS-Medicare

Recent Oncology Related Articles

• End of PHE
• Cannabidiol Advisory
• Future of Medicare Enrollment 
• Recent Learn Resource & MedLearn Matters Articles
• And more

Details >

Quality

• QP Call For 2023 Measures Fact Sheet 
• Data Submission Window Is Now Open
• Updated Eligibility Information 
• 2021 QPP Performance Information

Details >

Recent RAC Monitor Article

This edition includes articles on

• AI in Healthcare is Here to Stay
• Four from Six: New Math, New Savings
• Two Decades of Supporting Laboratory Coding and Billing Best Practices

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

• Byooviz is No Longer Preferred Ranibizumab Drug
• Generic pemetrexed requires prior authorization 
• Commercial Subscriber IDs That Started With 99 Have Changed
• Additional Drugs to Require Prior Authorization
• And more

Details >

BCBSM/BCN

Publications

• The Record
• BCN Provider News

Details >
Section Header

Current Payer Issue Tracking Page

Last Reviewed/Updated 3/15/23

• Resolved: BCBSM Denials for Auth Exceeds Allowed
• Meridian Paying for Labs

Details >

Aetna

• Clinical Policy Bulletins
• Check Our Formulary
• Requirements for Part B Drugs

Details >

Medicaid

Recent Oncology Related News

Medicaid Updates Include
• NCCI Policy Manual
• MSA Bulletin Updates
• Biller "B" Aware Notices

Details >

Priority Health Update

• Virtual Office Advisory Webinars
• New Professional Claim Edits
• Appeal Tips
• And more

Details >

United Healthcare

• Medical Policy Updates
• Reimbursement Policy Updates
• Coverage Summary Updates
• And more

Details >
Section Header

Recent Oncology Related FDA Approvals and Expanded Indications

• Coherus UDENYCA® Autoinjector
• Lilly Verzenio® (abemaciclib)

Details >
Section Header Section Header

ASK MSHO

March 2023 Frequently Asked Questions

• Date of Service
• Codes 96360 and 96361 for CAR-T
• What Constitutes as the Central Portion of the Breast

Details >